Mylan Warned by FDA Over India Drug Plant’s Quality Controls
People walk towards the Mylan NV factory in the Maharashtra Industrial Development Corp. area in Nashik, Maharshtra, India. (Photographer: Dhiraj Singh/Bloomberg)

Mylan Warned by FDA Over India Drug Plant’s Quality Controls

Bookmark
(Bloomberg) -- Mylan NV received a warning from U.S. regulators for failing to ensure key drug ingredients made at one of its plants in India were not contaminated.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.